Redmile Group’s Cyclacel Pharmaceuticals CYCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-1
Closed -$3.18M 53
2013
Q2
$3.18M Buy
+1
New +$3.18M 0.56% 38